The expression of ALDH1A1 has been reported as a favorable prognostic factor in HCC, being significantly associated in previous literature with low serum levels of alpha–fetoprotein, well-differentiated pathology and a favorable clinical outcome [36–38]. Here, ALDH1A1 is linked to hepatocellular carcinoma.